XERMELO 250 MG
TELOTRISTAT ETHYL (TELOTRISTAT ETIPRATE) : 250 MG · DIN 02481553 · SERB SAS
Health Canada status: MARKETED
What is XERMELO?
XERMELO 250 MG contains TELOTRISTAT ETHYL (TELOTRISTAT ETIPRATE) : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02481553, held by SERB SAS, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 02-Jul-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is XERMELO used for?
XERMELO (telotristat ethyl) is indicated for the treatment of refractory carcinoid syndrome diarrhea, in combination with somatostatin analogue (SSA) therapy, in patients inadequately controlled by SSA therapy alone.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02481553 |
|---|---|
| Brand name | XERMELO |
| Generic / active ingredient | TELOTRISTAT ETHYL (TELOTRISTAT ETIPRATE) : 250 MG |
| Manufacturer | SERB SAS |
| Strength | 250 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A16AX15 TELOTRISTAT |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 02-Jul-2024 |
How is it stored and handled?
null
How is it supplied?
blister packs packaged in cartons of 90 tablets
Who else supplies TELOTRISTAT worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TELOTRISTAT appears in 6 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.